Home Cart 0 Sign in  

[ CAS No. 2075-45-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 2075-45-8
Chemical Structure| 2075-45-8
Structure of 2075-45-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 2075-45-8 ]

Related Doc. of [ 2075-45-8 ]

Alternatived Products of [ 2075-45-8 ]
Product Citations

Product Details of [ 2075-45-8 ]

CAS No. :2075-45-8 MDL No. :MFCD00075602
Formula : C3H3BrN2 Boiling Point : -
Linear Structure Formula :(C3H3N2)Br InChI Key :WVGCPEDBFHEHEZ-UHFFFAOYSA-N
M.W : 146.97 Pubchem ID :16375
Synonyms :
Chemical Name :4-Bromo-1H-pyrazole

Calculated chemistry of [ 2075-45-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 6
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 26.29
TPSA : 28.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.0 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.74
Log Po/w (XLOGP3) : 0.28
Log Po/w (WLOGP) : 1.17
Log Po/w (MLOGP) : 0.41
Log Po/w (SILICOS-IT) : 1.95
Consensus Log Po/w : 0.91

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.54
Solubility : 4.2 mg/ml ; 0.0286 mol/l
Class : Very soluble
Log S (Ali) : -0.44
Solubility : 52.9 mg/ml ; 0.36 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.07
Solubility : 1.26 mg/ml ; 0.00859 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.15

Safety of [ 2075-45-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P264-P271-P280-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2075-45-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2075-45-8 ]
  • Downstream synthetic route of [ 2075-45-8 ]

[ 2075-45-8 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 2075-45-8 ]
  • [ 50901-46-7 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1982, vol. 18, p. 6 - 10[2] Zhurnal Organicheskoi Khimii, 1982, vol. 18, # 1, p. 9 - 14
  • 2
  • [ 2075-45-8 ]
  • [ 4333-56-6 ]
  • [ 1151802-23-1 ]
YieldReaction ConditionsOperation in experiment
68% With caesium carbonate In N,N-dimethyl-formamide at 180℃; for 1.5 h; Microwave irradiation Step 1 : 4-Bromo- 1 -cyc A mixture of 4-bromo-lH-pyrrazole (1.0 g, 6.8 mmol), bromo cyclopropane (1.3 g, 10.7 mmol), cesium carbonate (3.5 g. 10.7 mmol), and DMF (6 mL) in a 30 mL microwave vial is heated to 180 °C under radiation for 1.5 hr. After cooled to room temperature, the reaction mixture is filtered. The filtrate is concentrated and the residue is purified on a silica gel flash chromatography with ethyl acetate/petroleum ether (1 :5) to get a brown liquid (0.87 g, 68percent yield). (MS: [M+l] 259)
Reference: [1] Patent: WO2014/32498, 2014, A1, . Location in patent: Page/Page column 14
[2] Patent: US2015/31673, 2015, A1, . Location in patent: Paragraph 0334
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Pharmaceutical Intermediates of
[ 2075-45-8 ]

Ruxolitinib Related Intermediates

Chemical Structure| 1146629-77-7

[ 1146629-77-7 ]

(4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate

Chemical Structure| 269410-08-4

[ 269410-08-4 ]

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

Chemical Structure| 591769-05-0

[ 591769-05-0 ]

3-Cyclopentylacrylonitrile

Chemical Structure| 73183-34-3

[ 73183-34-3 ]

4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi(1,3,2-dioxaborolane)

Chemical Structure| 1029716-44-6

[ 1029716-44-6 ]

1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

Related Functional Groups of
[ 2075-45-8 ]

Bromides

Chemical Structure| 15803-02-8

[ 15803-02-8 ]

4-Bromo-1-methyl-1H-pyrazole

Similarity: 0.85

Chemical Structure| 16461-94-2

[ 16461-94-2 ]

4-Bromo-1H-pyrazol-3-amine

Similarity: 0.83

Chemical Structure| 13808-64-5

[ 13808-64-5 ]

4-Bromo-3-methylpyrazole

Similarity: 0.81

Chemical Structure| 71229-85-1

[ 71229-85-1 ]

4-Bromo-1-ethyl-1H-pyrazole

Similarity: 0.74

Chemical Structure| 5775-82-6

[ 5775-82-6 ]

4-Bromo-1,3-dimethyl-1H-pyrazole

Similarity: 0.71

Related Parent Nucleus of
[ 2075-45-8 ]

Pyrazoles

Chemical Structure| 15803-02-8

[ 15803-02-8 ]

4-Bromo-1-methyl-1H-pyrazole

Similarity: 0.85

Chemical Structure| 16461-94-2

[ 16461-94-2 ]

4-Bromo-1H-pyrazol-3-amine

Similarity: 0.83

Chemical Structure| 13808-64-5

[ 13808-64-5 ]

4-Bromo-3-methylpyrazole

Similarity: 0.81

Chemical Structure| 71229-85-1

[ 71229-85-1 ]

4-Bromo-1-ethyl-1H-pyrazole

Similarity: 0.74

Chemical Structure| 5775-82-6

[ 5775-82-6 ]

4-Bromo-1,3-dimethyl-1H-pyrazole

Similarity: 0.71

; ;